Jack Lepping

[Digital Health Awards @DHealthAwards]

BRONZE | Pharmacy Times @Pharmacy_Times | Health Workers Lead the Charge, Receiving First COVID-19 Vaccines in Rochester, New York (Digital Health Media / Publications: Video) #Spring2021DHA

[Pharmacy Times @Pharmacy_Times]

Find out all #pharmacist-recommended products in the #OTCGuide

https://t.co/D3qnlRbsUc

[Gina Mauro @ginacolumbusonc]

LISTEN NOW: Sapna Patel, MD, of MD Anderson Cancer Center, discusses a new collaboration between The University of Texas MD Anderson Cancer Center and TriSalus™ Life Sciences on this week's episode of OncLive on Air! https://t.co/rRoLzfzlMe

[PER @gotoPER]

This session with @DrEzraCohen is designed to help physicians discuss the best practices for optimizing immuno-oncology treatments in the clinic and mitigating predictable treatment-related adverse events. https://t.co/q51nAJrcp8 #FutureofOncologyNOW2021 #Oncology

[PER @gotoPER]

In this live, virtual satellite symposium, an expert panel with program chair, @CharuAggarwalMD, will review updated strategies to improve the application and interpretation of testing in NSCLC. Tune in on June 22. https://t.co/to6Jcp3nf5 #FutureofOncologyNOW2021

[The Cancer Letter @TheCancerLetter]

.@cotahealthcare's Miruna Sasu: I left pharma to “turn the spigot on” in the real-world data industry. #realworlddata
https://t.co/ulB3ca19lF

[Sagar Lonial MD @SagarLonialMD]

Beware of the siren song of early MRD. Consolidation with hdt adds significant value as measured by pfs which is the important endpoint and shows that mrd is not always a surrogate for pfs. look at tue RVD 1000 data, pfs for SR is >75 months with transplant and Len maintenance

[Jorge Cortes MD @jorgecortesmd]

For my upcoming birthday I wanted to do something special. I donated blood. I hope you will do the same, for your birthday or for mine. A great present to give to someone who needs it.

[Dana-Farber @DanaFarber]

A new study led by researchers at Dana-Farber, Massachusetts General Hospital, and Harvard Medical School presents the most in-depth account of a tumor’s evolution across all phases of its existence https://t.co/9ALUHL9CuJ

[Rare Disease Report @RareDR]

“It really takes a whole team of individuals in order to provide the best quality care for somebody with #cysticfibrosis."

Pediatric pulmonologist Jordana Hoppe, MD, of @ChildrensColo, discusses CF, treatment options, management, and more.

https://t.co/a272muFh9y

[Contagion @Contagion_Live]

We recently sat down to discuss #nanoparticle and #adenovirus vaccine platforms with investigators from @TheWistar institute. #COVID19

https://t.co/jlJx3Rah2A

[Contagion @Contagion_Live]

Cartesian Therapeutics has created its therapy, Descartes-30, the first #RNA cell therapy for acute respiratory distress syndrome which is now recruiting for a clinical trial. #COVID19 #ARDS

https://t.co/1ndctZFVvY

[Atlantic Health @AtlanticHealth]

As we spend more time outdoors, it's critical to understand risks the sun poses if you have #melanoma or an elevated risk of skin cancer. Eric Whitman, MD, FACS, medical director of Atlantic Health System Cancer Care, answers some FAQ's. https://t.co/yVF3aMiqTI
@Melanoma_doctor

[Eric D Whitman, MD @Melanoma_doctor]

Agree completely

[CURE Today @cure_today]

#CureConnect A3 – Here, @Martha__Carlson explains that while music therapy isn't the same for everyone, it’s beneficial to find some joy in music - and maybe even push away a moody cancer funk. https://t.co/PDAPFQgpIr

[Yelena Y. Janjigian MD @YJanjigianMD]

The future is bright for #HER2 gastric ca pts. @LumishMelissa used 89Zr-trastuzumab PET to identify HER2 heterogeneity in gastric ca pts. Innovative work @sloan_kettering recognized by #ASCO21 Merit Award 🥇 @OncoAlert @LewisLabMSKCC @ConquerCancerFd https://t.co/1uZKhhAsB8

[Oncology Tube @oncologytube]

FDA Approves Pembrolizumab With Trastuzumab And Chemotherapy As First-line Treatment Yelena Y. Janjigian, MD @YJanjigianMD @sloan_kettering @MSKCC #GastricCancer #GastroesophagealCancer #Cancer #Research

https://t.co/LVkP9QLiRK...

[Dr. Shubham Pant @DrShubhamPant]

👏👏👏Great job @AliSchram @EileenMOReilly and NRG1 collaborators! Amazing RR of 42% in #PancreaticCancer. The future is bright!! @ASCO @PanCAN @OncoAlert @GarridoLagunaMD @MPishvaian @GIcancerDoc @letswinpc

[Dr. Shubham Pant @DrShubhamPant]

📢Don't miss "Now and Next in Pancreatic Cancer" at #ASCO21
👉Overview of systemic therapies: Maeve Lowery @CancerInstIRE
👉Oligometastatic disease: Matthew J. Weiss @NorthwellHealth
👉 Incorporating NGS in clinic
@ASCO @OncoAlert @MDAndersonNews
https://t.co/Jj9Yo6xkp5

[Naval Daver, M.D. @Daver_Leukemia]

What exciting times for AML therapies and research, moving from hydrea to single agent HMA to HMA+VEN to triplet in <15 years. The Lamborghini of cancers :-). Great work @musayilmaz54 @MDAndersonNews and team.